retatrutide expected approval date Remember, it is still in Phase 3 trial. Not yet FDA approved. to be approved in 2027 or early 2028 Retatrutide Availability & Timeline |

References to supplements and products do not imply treatment, prevention or cure of any medical conditions

Adam Kautzner, president of pharmacy benefits manager Express Scripts, said during the company's investor day that the market for GLP-1s could grow to $100 billion by the end of the decade

Tracking the right metrics during your transition from tirzepatide to retatrutide provides objective data about whether the switch is working, whether your dose needs adjustment, and whether you are experiencing the full benefit of triple receptor agonism

Rub the soap gently to form a lather and apply it evenly over the affected area

Not only to ensure the safety of you and any potential pregnancy, but to make sure your treatment plan is truly tailored to you

Track the number of doses used to know when replacement is needed